Products
Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.
NeuroLens®
Neuron Cell-Death Test
RNA Clarity™
RNA Vaccine QC
MethylMap™
Native-Read Methylation Sequencing
Older woman discussing a clinical diagnosis with a female doctor who is reviewing a tablet in a medical office.
Services
Services
End-to-end sequencing services supporting genomic, epigenomic, and transcriptomic analysis, from experimental design and assay development to bioinformatics, interpretation, and data delivery.
Applications
Applications
Explore how our products and services help solve difficult biological and genomic problems, from liquid biopsy signals to complex regions and emerging biomarker development.
Hard-to-Sequence Genes & Complex Regions
Liquid Biopsy cfDNA Analysis
Targeted Panel Development
Close-up of overlapping teal and green curved panels with light reflections and a smooth gradient.
Company
Company
Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
About Us
Development & Validation
Team
Building with a black facade featuring white 3D letters spelling 'RENEW' and a geometric logo.
Resources
Contact
  • Applications
  • Applications
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging, cancer, and neurodegeneration research.
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging.
    Research & Translation
    Biopharma Research
    Clinical Development
    Abstract digital pattern of glowing rectangular bars in green and blue on a dark background.

Our Team

Leadership
Renew Biotechnologies leadership team brings together scientific, clinical, and operational experience to guide the company’s strategy, partnerships, and long-term vision for sequencing-driven diagnostics.
Chad Pollard, PhD
Chief Executive Officer Co-Founder
Jonathon Hill, PhD
VP of Science and Technology Co-Founder
Tim Jenkins, PhD
VP of Research and Discovery Co-Founder
Bruce Hassler
Chief Technology Officer
Steve Abott
Chief Operating Officer
Mitchell Fowler
Fractional Chief Financial Officer
Clinical
Renew Biotechnologies clinical experts help translate complex genomic, epigenetic, and transcriptomic insights into clinically meaningful applications for precision diagnostics and research.
Benjamin R. Emery, M.Phil., T.S.
Director of Compliance
Ki Aston, PhD, HCLD
Lab Director
Jeffrey M. Burns, MD, MS
Medical Advisor
Operating Team
Renew Biotechnologies brings together experienced scientists and operators focused
on advancing innovation through discipline, reliability, and focus.
Alan Pollard
VP of Commercial
Andrew Jenkins
Research Associate
Andrew Klayman
Senior Designer
Bailey Ludloff
Accounting Manager
Chase Christensen
Director of Customer and Employee Success
Dean Lilley
Senior Director, Product & Business Development
Dillon Craw
Software Developer
Erin Saito, PhD
Director of Medical Writing
Hailey Johnson
Associate Bioinformatics Scientist
Isaac Stirland, PhD
Research Associate
Jacob Hutchings
Principal Software Engineer
Jared Renberg
Software Developer
Joe Watson
Director of Quality Assurance
Jon Locke, MLS (ASCP)
Senior Lab Associate
Jordan Moore
Associate Bioinformatics Scientist
Kelaney Stalker
Project Manager
Mykle Keni
Research Associate
Payton Carter, MS
Bioinformatics Scientist
Ryan Barney, PhD
Laboratory Manager
Ryan Miller, MS
Senior Data Scientist
Zac Rae
Senior Sales Executive
Discover More
Join For Updates
Success! Thank you for joining our newsletter.
Oops! Something went wrong while submitting the form.
© 2026 Renew Biotechnologies | All Rights Reserved
CAP 7654476 | CLIA 46D2309073